Clinical Trial Update: Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies [EARLY_Phase 1]

View source ↗

Summary

An exploratory Phase 1 study is evaluating an mRNA therapy targeting CD19 for B-cell malignancies. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Malignancies
• Hematologic Malignancies

Drugs mentioned

• CD19-targeted mRNA therapeutic

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: B-cell Malignancies | EARLY_Phase 1 | Status: RECRUITING